Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2009 Nov 12;8(3):289–296.e8. doi: 10.1016/j.cgh.2009.10.034

Table 3A.

Histologic variables in stage F0 biopsies of rapid and slow fibrosers.

Rapid Fibrosers Slow Fibrosers P value
N with available stage 0 biopsy for review 26 44
Portal tract density Median (25-75 percentiles) 1 (0.75-2.0) 1 (1.0-2.0) .7433
Portal tract activity Median (25-75 percentiles) 1 (0-2.0) 0.5 (0-1.0) .3442
Lobular activity Median (25-75 percentiles) 1 (0-2.0) 1 (0.25-2.0) .9125
N with steatosis
Present (%) 4 (15.38) 16 (36.36) .0992
Absent (%) 22 (84.62) 28 (63.64)
N with plasma cells
Present (%) 2 (7.69) 3 (6.82) 1
Absent (%) 24 (92.31) 41 (93.18)
Apoptotic cells/high power field Mean ± SD 0.30 ± 0.38 0.08 ± 0.16 .0012

The first 3 parameters were scored from 0-3, with 3 being the highest score.

HHS Vulnerability Disclosure